The processing records for sgpv00, serial number (b)(4) were reviewed and it was determined that all attributes identified were documented appropriately and the allograft met specifications.The previous sano shunt was removed and replaced with an sgpv sano shunt.The patient¿s medical history contained acute heart failure, aortic stenosis, cyanosis, double outlet right ventricle; truncus arteriosus type 4, dysplastic aortic valve, left coronary artery stenosis, patent ductus arteriosus, pulmonary atresia, and ventricular septal defect.The use of valved homografts as rv-pa conduits in stage i of the modified norwood procedure has been described in literature and has increased in popularity over the bt shunt due to improved outcomes relating to increased postoperative hemodynamic stability (reinhartz 2006, shinkawa 2015, christenson 2010).The patient¿s history of severe congenital heart disease, abnormal cardiac anatomy, and failed sano shunt were likely contributing factors to the reported cause of death as cardiac failure.There is no indication that an error or deficiency occurred at cryolife.The risk management file thoroughly identifies the process and product hazards for approved indications.Each individual hazard is mitigated and reduced as low as possible by design and process.This event does not identify additional hazards or modify the probability and severity of existing hazards.
|